您的购物车当前为空
α-Glucosidase-IN-32 (compound f26),是一种口服有效的α-glucosidase抑制剂,具有可逆、非竞争性特点,IC50值为3.07 μM。该化合物通过与α-glucosidase形成氢键和疏水相互作用,以改变其构象和二级结构,从而抑制酶活性。α-Glucosidase-IN-32 主要用于糖尿病研究。
α-Glucosidase-IN-32 (compound f26),是一种口服有效的α-glucosidase抑制剂,具有可逆、非竞争性特点,IC50值为3.07 μM。该化合物通过与α-glucosidase形成氢键和疏水相互作用,以改变其构象和二级结构,从而抑制酶活性。α-Glucosidase-IN-32 主要用于糖尿病研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
α-Glucosidase-IN-32 相关产品
| 产品描述 | α-Glucosidase-IN-32 (compound f26) is a reversible, noncompetitive inhibitor of α-glucosidase that is orally active and exhibits an IC50 of 3.07 μM. It forms a complex with α-glucosidase via hydrogen bonding and hydrophobic interactions, inducing conformational and secondary structure changes in the enzyme, thereby inhibiting its activity. This compound is utilized in diabetic disease research [1]. |
| 分子量 | 510.61 |
| 分子式 | C32H22N4OS |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容